Application no. and date | 20722936.0 (espacenet) (Federated) (European Patent Register), 20200410 | Patent/reg. no. and date | DK/EP 3856341, 20230906 | Publication date | 20210804 | Priority no. and date | US 201962833527 P, 20190412, US 201962844575 P, 20190507, US 202062990269 P, 20200316 | EP pub. no. and date |
EP 3856341 20210804 | Effective date | | Applicant/owner | Blueprint Medicines Corporation, 45 Sidney Street
Cambridge, MA 02139, US | Applicant ref. no. | 23882DK00 | Inventor | WAETZIG, Joshua, D., 45 Sidney Street
Cambridge, MA 02139, US, MAR, Brenton, 45 Sidney Street
Cambridge, MA 02139, US, HEINRICH, Brian, 45 Sidney Street
Cambridge, MA 02139, US, WILKIE, Gordon, 45 Sidney Street
Cambridge, MA 02139, US, MACEACHERN, Lauren, 39 Oathill Crescent
Dartmouth, Nova Scotia, B2Y4C3, CA | Representative | Inspicos P/S, Agern Alle 24 , 2970 Hørsholm | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61P 17/00 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , C07D 487/04 (2006.01) | Title | KRYSTALLINSKE FORMER AF (S)-1-(4-FLUORPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMIN OG FREMGANGSMÅDER TIL FREMSTILLING DERAF | Int. application no. | US2020027724 | Int. publication no. | WO2020210669 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|